Medicine · Diabetes Mellitus and Endocrine Disorders (Thyroid, Adrenal, Pituitary, Parathyroid)

Which molecular event explains the insulin secretagogue action of sulfonylureas?

  • A Closure of ATP-sensitive potassium channels on the pancreatic beta cell membrane
  • B Activation of hepatic AMP kinase, reducing gluconeogenesis
  • C Inhibition of renal sodium-glucose cotransporter 2
  • D Agonism of glucagon-like peptide-1 receptors on beta cells
Correct answer: A. Closure of ATP-sensitive potassium channels on the pancreatic beta cell membrane

Explanation

Sulfonylureas bind SUR1, a subunit of the beta-cell ATP-sensitive potassium channel, closing the channel. The resulting membrane depolarisation opens voltage-gated calcium channels, calcium enters, and preformed insulin granules are released. This mechanism is insulin-independent of ambient glucose, which explains both their efficacy and their propensity to cause hypoglycaemia. Option B describes metformin and option D describes incretin-based drugs such as sitagliptin and semaglutide.

Reference: Katzung's Basic and Clinical Pharmacology, 16th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Diabetes Mellitus and Endocrine Disorders (Thyroid, Adrenal, Pituitary, Parathyroid) MCQs

See all Diabetes Mellitus and Endocrine Disorders (Thyroid, Adrenal, Pituitary, Parathyroid) MCQs →